NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

體外膜氧合(ECMO)的全球市場:由於COVID-19大流行和呼吸系統疾病的患病率上升而迅速增長

COVID-19 Pandemic and Rising Prevalence of Respiratory Disorders Catapult Growth in Global Extracorporeal Membrane Oxygenation (ECMO) Market

出版商 Frost & Sullivan 商品編碼 987573
出版日期 內容資訊 英文 81 Pages
商品交期: 最快1-2個工作天內
價格
體外膜氧合(ECMO)的全球市場:由於COVID-19大流行和呼吸系統疾病的患病率上升而迅速增長 COVID-19 Pandemic and Rising Prevalence of Respiratory Disorders Catapult Growth in Global Extracorporeal Membrane Oxygenation (ECMO) Market
出版日期: 2020年12月24日內容資訊: 英文 81 Pages
簡介

由於最近發生的COVID-19大流行,體外膜氧合作用(ECMO)療法備受關注。這是由於救生的重要性,它可以改善氧氣供應,同時為因病毒感染而導致的急性呼吸窘迫綜合徵(ARDS)患者的肺組織提供足夠的癒合時間。在2009年甲型H1N1流感大流行之後,急診醫生已開始廣泛接受ECMO治療。

預計全球體外膜氧合(ECMO)市場將以個位數中位數逐漸增長。這是由於慢性阻塞性肺疾病(COPD)病例的增加以及在採用主流ECMO治療的支持下,作為恢復心肺狀態的恢復,移植或心室輔助設備(VAD)的有益橋樑。推動採用ECMO的其他關鍵因素包括ECMO治療的主要適應症發生率高,技術進步以及傳統療法(例如機械呼吸)的不良結果。

本報告調查了全球體外膜氧合(ECMO)市場,包括市場趨勢和預測,COVID-19的影響,增長和限制因素,挑戰和機遇,產品和技術,並提供了諸如區域市場分析,競爭性等信息情況和主要公司的概況。

目錄

戰略帝國

增長機會分析

  • 市場定義
  • 市場分析範圍
  • 按產品和技術細分
  • 區域細分
  • 按部門:主要競爭對手
  • 體外膜氧合的優勢
  • 主要衝擊力推動了體外膜氧合的需求
  • 市場增長趨勢
  • 市場戰略勢在必行
  • 推動市場增長機會的關鍵因素
  • 從當前狀態(問題)到未來狀態(機會)的過渡
  • 競爭形勢
  • 主要市場增長指標
  • 市場上的重大收購
  • 技術進步快照
  • 市場增長因素
  • 市場限制
  • 預測先決條件
  • 收入預測快照
  • 收入預測
  • 按方式進行的收入預測
  • 按組成部分的收入預測
  • 按患者類型分類的收入預測
  • 各地區收入預測
  • 收入預測分析
  • 區域趨勢快照
  • 各地區收入預測分析
  • 競爭環境
  • 收入份額:市場主要參與者
  • 收入份額分析:市場主要參與者
  • 競爭環境:主要競爭

主要競爭對手的概況

  • Medtronic
  • Getinge (Maquet)
  • LivaNova
  • Terumo
  • Nipro
  • Fresenius Medical Care(Xenios收購)
  • 其他

增長機會分析:北美

增長機會分析:歐洲

增長機會分析:亞太地區

增長機會宇宙

  • 增長機會1:加強對VV ECMO的長期使用的需求,並通過近期COVID-19危機帶來的積極的實際和試驗結果來促進創新
  • 增長機會2:新興的集成商和先進的電路解決方案驅動新興的增長戰略
  • 增長機會3:亞太新興市場的增長前景

下一步

目錄
Product Code: K56F-54

Next-generation Devices Improving Survival and Workflow Efficiencies Uncovering New Growth Opportunities

Extracorporeal membrane oxygenation (ECMO) therapy has been in the limelight during the recent COVID-19 pandemic. This was due to its live-saving importance by improving the oxygenation, while providing pulmonary tissues adequate healing time, in patients suffering from acute respiratory distress syndrome (ARDS) caused by the viral infection. However, ECMO therapy had started gaining wider acceptance among critical care physicians post the 2009 influenza A (H1N1) pandemic. The driver was the consecutive generation of clinical trial evidence and multiple research studies proving its benefits to respiratory failure compared to conventional ventilation.

The ECMO market is expected to grow gradually, in mid-single digits. This is in the backdrop of increasing chronic obstructive pulmonary disease (COPD) cases and mainstream ECMO therapy adoption due to its beneficial role as a bridge to recovery, transplant, or ventricular assist device (VAD) for cardiopulmonary conditions. Other major factors driving ECMO adoption are currently low market penetration or installed base, higher incidences of key indications for ECMO therapy, advancements in technology, and poor outcomes from conventional therapies like mechanical ventilation. Survival rates with ECMO therapy have improved due to advancements in simplified circuit designs, specifically in oxygenators and blood pumps to enhance gas exchange, minimize hemolysis, and prevent clotting and bleeding risks; and the introduction of standardized protocols in high-volume ECMO centers with dedicated capabilities.

The market is concentrated with very few established participants, like Medtronic, Getinge, LivaNova and Terumo, along with emerging challengers, like Xenios (Fresenius Medical), Eurosets, Spectrum Medical, and OriGen Biomedical. There are also several disruptive participants, like ALung Technologies and Hemovent, with newly launched products. Established Tier I participants, like Medtronic, Terumo, and Getinge, are competitively positioned in the specialized components space. However, the market is transforming toward offering integrated systems with advanced monitoring capabilities due to greater emphasis on safety, simplification and compactness, and ease of usage. Though the ECMO market has not seen fierce inorganic growth strategies, there have been a few notable ones, like the Fresenius Medical-Xenios deal in 2016, LivaNova-TandemLife deal in 2019, and Abiomed-Breethe deal in 2020.

Key Issues Addressed:

  • What are the main trends in extracorporeal membrane oxygenation (ECMO) therapy?
  • Who are the top market participants in the ECMO market?
  • What is the competitive landscape of the ECMO market?
  • What are the ECMO market's key growth drivers and restraints?
  • How would the ECMO market be in 5 years' time? What are the market forecasts from 2019 to 2025?
  • What are the growth opportunities for the ECMO market?

Table of Contents

Strategic Imperatives

  • Why is it Increasingly Difficult to Grow?
  • The Strategic Imperative 8™
  • The Impact of the Top Three Strategic Imperatives on the Extracorporeal Membrane Oxygenation Market
  • Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis-Extracorporeal Membrane Oxygenation Market

  • Extracorporeal Membrane Oxygenation Market-Definition
  • Extracorporeal Membrane Oxygenation Market Scope of Analysis
  • Extracorporeal Membrane Oxygenation Market Segmentation by Product and Technology
  • Extracorporeal Membrane Oxygenation Market Segmentation by Region
  • Extracorporeal Membrane Oxygenation Market-Key Competitors by Segment
  • Benefits of Extracorporeal Membrane Oxygenation
  • Key Impact Forces Driving the Need for Extracorporeal Membrane Oxygenation
  • Growth Trends in the Extracorporeal Membrane Oxygenation Market
  • Strategic Imperatives on the Extracorporeal Membrane Oxygenation Market
  • Key Factors Driving Growth Opportunity in the Extracorporeal Membrane Oxygenation Market
  • Transition from Current State (Issues) to Future State (Opportunities)
  • Extracorporeal Membrane Oxygenation Market-Competitive Landscape
  • Key Growth Metrics for the Extracorporeal Membrane Oxygenation Market
  • Key Acquisitions in the Extracorporeal Membrane Oxygenation Market
  • Snapshot of Extracorporeal Membrane Oxygenation Technology Advancements
  • Growth Drivers for the Extracorporeal Membrane Oxygenation Market
  • Growth Restraints for the Extracorporeal Membrane Oxygenation Market
  • Forecast Assumptions-Extracorporeal Membrane Oxygenation Market
  • Revenue Forecast Snapshot-Extracorporeal Membrane Oxygenation Market
  • Revenue Forecast-Extracorporeal Membrane Oxygenation Market
  • Revenue Forecast by Modality-Extracorporeal Membrane Oxygenation Market
  • Revenue Forecast by Component-Extracorporeal Membrane Oxygenation Market
  • Revenue Forecast by Patient Type-Extracorporeal Membrane Oxygenation Market
  • Revenue Forecast by Region-Extracorporeal Membrane Oxygenation Market
  • Revenue Forecast Analysis-Extracorporeal Membrane Oxygenation Market
  • Revenue Forecast Analysis-Extracorporeal Membrane Oxygenation Market (continued)
  • Revenue Forecast Analysis-Extracorporeal Membrane Oxygenation Market (continued)
  • Regional Trends Snapshot-Extracorporeal Membrane Oxygenation Market
  • Revenue Forecast Analysis by Region-Extracorporeal Membrane Oxygenation Market
  • Competitive Environment-Extracorporeal Membrane Oxygenation Market
  • Revenue Share-Top Participants of Extracorporeal Membrane Oxygenation Market
  • Revenue Share Analysis-Top Participants of Extracorporeal Membrane Oxygenation Market
  • Competitive Environment-Key Competitors: Extracorporeal Membrane Oxygenation Market

Key Competitor Profiles-Extracorporeal Membrane Oxygenation Market

  • Medtronic
  • Getinge (Maquet)
  • LivaNova
  • Terumo
  • Nipro
  • Fresenius Medical Care (acquired Xenios)
  • Other Emerging Competitors-Extracorporeal Membrane Oxygenation Market

Growth Opportunity Analysis-Extracorporeal Membrane Oxygenation Market: NA

  • Key Growth Metrics for Extracorporeal Membrane Oxygenation Market-NA
  • Revenue Forecast for Extracorporeal Membrane Oxygenation Market-NA
  • Revenue Forecast by Modality for Extracorporeal Membrane Oxygenation Market-NA
  • Forecast Analysis for Extracorporeal Membrane Oxygenation Market-NA

Growth Opportunity Analysis-Extracorporeal Membrane Oxygenation Market: EU

  • Key Growth Metrics for Extracorporeal Membrane Oxygenation Market-EU
  • Revenue Forecast for Extracorporeal Membrane Oxygenation Market-EU
  • Revenue Forecast by Modality for Extracorporeal Membrane Oxygenation Market-EU
  • Forecast Analysis for Extracorporeal Membrane Oxygenation Market-EU

Growth Opportunity Analysis-Extracorporeal Membrane Oxygenation Market: APAC

  • Key Growth Metrics for Extracorporeal Membrane Oxygenation Market-APAC
  • Revenue Forecast for Extracorporeal Membrane Oxygenation Market-APAC
  • Revenue Forecast by Modality for Extracorporeal Membrane Oxygenation Market-APAC
  • Forecast Analysis for Extracorporeal Membrane Oxygenation Market-APAC

Growth Opportunity Universe-Extracorporeal Membrane Oxygenation Market

  • Growth Opportunity 1: Positive Actual and Trial Outcomes from Recent COVID-19 Crisis Can Bolster Demand and Drive Innovations for VV ECMO's Long-term Use
  • Growth Opportunity 1: Positive Actual and Trial Outcomes from Recent COVID-19 Crisis Can Bolster Demand and Drive Innovations for VV ECMO's Long-term Use (continued)
  • Growth Opportunity 2: Emergence of New Participants with Integrated and Advanced Circuit Solutions Set to Drive Inorganic Growth Strategy
  • Growth Opportunity 2: Emergence of New Participants with Integrated and Advanced Circuit Solutions Set to Drive Inorganic Growth Strategy (continued)
  • Growth Opportunity 3: Emerging Markets in APAC Showing Promise of Growth Due to Multiple Tailwinds
  • Growth Opportunity 3: Emerging Markets in APAC Showing Promise of Growth Due to Multiple Tailwinds (continued)

Next Steps

  • Your Next Steps
  • Why Frost, Why
  • List of Exhibits
  • List of Exhibits (continued)
  • Legal Disclaimer